Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Treasury Shares (2016 - 2025)

Bio-Techne has reported Treasury Shares over the past 16 years, most recently at $22000.0 for Q2 2025.

  • Quarterly results put Treasury Shares at $22000.0 for Q2 2025, down 95.57% from a year ago — trailing twelve months through Jun 2025 was $22000.0 (down 95.57% YoY), and the annual figure for FY2025 was $22000.0, down 95.57%.
  • Treasury Shares for Q2 2025 was $22000.0 at Bio-Techne, down from $497000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for TECH hit a ceiling of $1.4 million in Q4 2023 and a floor of $22000.0 in Q2 2025.
  • Median Treasury Shares over the past 5 years was $106000.0 (2021), compared with a mean of $312200.0.
  • Biggest five-year swings in Treasury Shares: soared 1243.24% in 2024 and later plummeted 95.57% in 2025.
  • Bio-Techne's Treasury Shares stood at $89000.0 in 2021, then skyrocketed by 149.44% to $222000.0 in 2022, then soared by 529.28% to $1.4 million in 2023, then plummeted by 64.42% to $497000.0 in 2024, then plummeted by 95.57% to $22000.0 in 2025.
  • The last three reported values for Treasury Shares were $22000.0 (Q2 2025), $497000.0 (Q2 2024), and $1.4 million (Q4 2023) per Business Quant data.